Sign In
NewsRadar

KINAXO Biotechnologies GmbH

KINAXO Biotechnologies is a spin-off from the Max-Planck Institute for Biochemistry in Martinsried. KINAXO offers a comprehensive chemical-proteomics technology - known as KinaTorTM - to identify and characterize the biological interactions of kinase inhibitors with their cellular protein targets.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Am Klopferspitz 19a
Martinsried 82152
Germany
+49 (0)89 700 7368 31
+49 (0)89 700 7368 33
http://www.kinaxo.com
Andreas Jenne
+49 172 8710 562

Company Facts
Founded:
Founders:Henrik Daub, Hellmut Kirchner, Andreas Jenne, Alex Ullrich, Axel Leimer
CEO:Andreas Jenne
CTO or technical lead:Klaus Godl
CFO or finance director:
Head of Sales:Jutta Fritz
Head of Marketing:

Stage:Early Stage
Category:Biotechnology & Healthcare
Sector:Biotechnology
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

  • Matthias Stein-Gerlach, Patent and Licensing Manager, Garching Innovation
  • Hellmut Kirchner, Managing Director, VCM Capital Management
  • Axel Ullrich, Max Planck-Institute of Biochemistry
  • Bernhard Wimmer, Investment Manager, BioM
  • Henrik Daub, Group Leader, Max Planck-Institute of Biochemistry
  • Alex Leimer, President, Leimer Industry Strategy Consulting

    Key Customers

    Key Business Partners

    Key Competitors

    Capital Raised
    DateSizeInvestors
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    DateTypeExchange
    No public offerings


  • Data


    26,673
    Tech investments
    From our Online Data Service
    17,217
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Nov 25€24.0MInternet commerce
    Feb 14€19.0MBiopharmaceuticals
    Feb 14N/AInternet services
    Feb 14€4.6MBusiness applications
    Feb 13€13.0MBiopharmaceuticals
    Feb 13€25.0MMedical devices
    Feb 13€15.0MBusiness applications

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    May 28
    Identiq
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    Nethone
    nethone raised over $1 million from innovation nest

    Jan 29
    Yumpingo
    yumpingo raises $10m to transform guest experiences in restaurants

    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase





    About usContact usLegal Information
    Copyright 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.